Firefly Neuroscience, Inc. reported significant financial developments in its recent 10-K filing for the fiscal year ending December 31, 2025. The company generated revenue of $1.142 million, a substantial increase of 957% compared to $108,000 in the previous fiscal year. This growth is primarily attributed to the acquisition of Evoke Neuroscience, which has expanded Firefly's product offerings and market reach. Despite this revenue increase, the company reported an operating loss of $8.856 million, an improvement from the $10.054 million loss in 2024, indicating a reduction in operational losses.
Operating expenses for Firefly totaled $9.501 million, down from $10.162 million in the prior year. Notably, research and development expenses decreased by 24% to $1.482 million, while selling and marketing expenses also saw a decline of 33% to $800,000. However, general and administrative expenses rose by 13% to $6.968 million, largely due to increased costs associated with directors and officers insurance following the merger. The company also recognized impairment expenses of $251,000 related to assets that were no longer expected to be utilized.
Firefly's operational metrics indicate a growing customer base, with the Evoke System actively deployed across more than 85 clinical sites in the United States. The company operates on a subscription-based model, which is designed to create a recurring revenue stream that scales with clinical utilization. As of December 31, 2025, Firefly had 17 full-time employees, reflecting its ongoing commitment to expanding its workforce to support its growth strategy.
Looking ahead, Firefly faces significant liquidity challenges, with an accumulated deficit of $111.615 million and negative cash flows from operations of approximately $8.194 million for the year. The company is actively pursuing additional capital through equity and debt financing to support its operations and growth initiatives. Management has expressed confidence in its ability to raise funds, but acknowledges the uncertainty surrounding capital markets and the potential impact on its business strategy. The company’s future profitability will depend on the successful commercialization of its products and the ability to manage operational costs effectively.
About FIREFLY NEUROSCIENCE, INC.
Firefly Neuroscience develops AI-driven neurophysiological assessment tools, notably the FDA-cleared BNA Platform, which analyzes EEG data to aid in diagnosing and managing neurological and mental health disorders. Its solutions support personalized treatment, clinical research, and drug development, targeting healthcare providers and pharmaceutical companies. Leveraging extensive proprietary databases and advanced machine learning, the company aims to transform brain health diagnostics and improve patient outcomes.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.